APA (7th ed.) Citation

Ota, H., Omori, H., Kawasaki, M., Hirakawa, A., & Matsuo, H. (2022). Clinical impact of PCSK9 inhibitor on stabilization and regression of lipid-rich coronary plaques: A near-infrared spectroscopy study. European heart journal cardiovascular imaging, 23(2), 217. https://doi.org/10.1093/ehjci/jeab034

Chicago Style (17th ed.) Citation

Ota, Hideaki, Hiroyuki Omori, Masanori Kawasaki, Akihiro Hirakawa, and Hitoshi Matsuo. "Clinical Impact of PCSK9 Inhibitor on Stabilization and Regression of Lipid-rich Coronary Plaques: A Near-infrared Spectroscopy Study." European Heart Journal Cardiovascular Imaging 23, no. 2 (2022): 217. https://doi.org/10.1093/ehjci/jeab034.

MLA (9th ed.) Citation

Ota, Hideaki, et al. "Clinical Impact of PCSK9 Inhibitor on Stabilization and Regression of Lipid-rich Coronary Plaques: A Near-infrared Spectroscopy Study." European Heart Journal Cardiovascular Imaging, vol. 23, no. 2, 2022, p. 217, https://doi.org/10.1093/ehjci/jeab034.

Warning: These citations may not always be 100% accurate.